Literature DB >> 11432843

Human immunodeficiency virus type 1 integrase: arrangement of protein domains in active cDNA complexes.

K Gao1, S L Butler, F Bushman.   

Abstract

Early steps of retroviral replication involve reverse transcription of the viral RNA genome and integration of the resulting cDNA copy into a chromosome of the host cell. The viral-encoded integrase protein carries out the initial DNA breaking and joining reactions that mediate integration. The organization of the active integrase-DNA complex is unknown, though integrase is known to act as a multimer, and high resolution structures of the isolated integrase domains have been determined. Here we use site-specific cross-linking based on disulfide bond formation to map integrase-DNA contacts in active complexes. We establish that the DNA-binding C-terminal domain of one integrase monomer acts with the central catalytic domain from another monomer at each viral cDNA end. These data allow detailed modeling of an integrase tetramer in which pairs of trans interactions link integrase dimers bound to substrate DNA. We also detected a conformational change in integrase- DNA complexes accompanying cleavage of the viral cDNA terminus.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11432843      PMCID: PMC125503          DOI: 10.1093/emboj/20.13.3565

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  48 in total

1.  The mobility of an HIV-1 integrase active site loop is correlated with catalytic activity.

Authors:  J Greenwald; V Le; S L Butler; F D Bushman; S Choe
Journal:  Biochemistry       Date:  1999-07-13       Impact factor: 3.162

2.  Crystal structure of an active two-domain derivative of Rous sarcoma virus integrase.

Authors:  Z N Yang; T C Mueser; F D Bushman; C C Hyde
Journal:  J Mol Biol       Date:  2000-02-18       Impact factor: 5.469

3.  Crystal structure of the HIV-1 integrase catalytic core and C-terminal domains: a model for viral DNA binding.

Authors:  J C Chen; J Krucinski; L J Miercke; J S Finer-Moore; A H Tang; A D Leavitt; R M Stroud
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

4.  Trans catalysis in Tn5 transposition.

Authors:  T A Naumann; W S Reznikoff
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

5.  Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells.

Authors:  D J Hazuda; P Felock; M Witmer; A Wolfe; K Stillmock; J A Grobler; A Espeseth; L Gabryelski; W Schleif; C Blau; M D Miller
Journal:  Science       Date:  2000-01-28       Impact factor: 47.728

6.  Trapping of a catalytic HIV reverse transcriptase*template:primer complex through a disulfide bond.

Authors:  H Huang; S C Harrison; G L Verdine
Journal:  Chem Biol       Date:  2000-05

7.  Isolation and characterization of novel human immunodeficiency virus integrase inhibitors from fungal metabolites.

Authors:  D Hazuda; C U Blau; P Felock; J Hastings; B Pramanik; A Wolfe; F Bushman; C Farnet; M Goetz; M Williams; K Silverman; R Lingham; S Singh
Journal:  Antivir Chem Chemother       Date:  1999-03

8.  X-ray structure of simian immunodeficiency virus integrase containing the core and C-terminal domain (residues 50-293)--an initial glance of the viral DNA binding platform.

Authors:  Z Chen; Y Yan; S Munshi; Y Li; J Zugay-Murphy; B Xu; M Witmer; P Felock; A Wolfe; V Sardana; E A Emini; D Hazuda; L C Kuo
Journal:  J Mol Biol       Date:  2000-02-18       Impact factor: 5.469

9.  Three-dimensional structure of the Tn5 synaptic complex transposition intermediate.

Authors:  D R Davies; I Y Goryshin; W S Reznikoff; I Rayment
Journal:  Science       Date:  2000-07-07       Impact factor: 47.728

10.  HIV-1 integrase inhibitors that compete with the target DNA substrate define a unique strand transfer conformation for integrase.

Authors:  A S Espeseth; P Felock; A Wolfe; M Witmer; J Grobler; N Anthony; M Egbertson; J Y Melamed; S Young; T Hamill; J L Cole; D J Hazuda
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

View more
  66 in total

1.  Structure of a two-domain fragment of HIV-1 integrase: implications for domain organization in the intact protein.

Authors:  J Y Wang; H Ling; W Yang; R Craigie
Journal:  EMBO J       Date:  2001-12-17       Impact factor: 11.598

2.  Cofactors for human immunodeficiency virus type 1 cDNA integration in vitro.

Authors:  Kui Gao; Robert J Gorelick; Donald G Johnson; Frederic Bushman
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

3.  Mechanisms and inhibition of HIV integration.

Authors:  Christophe Marchand; Allison A Johnson; Elena Semenova; Yves Pommier
Journal:  Drug Discov Today Dis Mech       Date:  2006-07-01

4.  A new functional role of HIV-1 integrase during uncoating of the viral core.

Authors:  Marisa S Briones; Samson A Chow
Journal:  Immunol Res       Date:  2010-12       Impact factor: 2.829

5.  Division of labor within human immunodeficiency virus integrase complexes: determinants of catalysis and target DNA capture.

Authors:  Tracy L Diamond; Frederic D Bushman
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

6.  Single-particle image reconstruction of a tetramer of HIV integrase bound to DNA.

Authors:  Gang Ren; Kui Gao; Frederic D Bushman; Mark Yeager
Journal:  J Mol Biol       Date:  2006-11-11       Impact factor: 5.469

7.  Subunit-specific protein footprinting reveals significant structural rearrangements and a role for N-terminal Lys-14 of HIV-1 Integrase during viral DNA binding.

Authors:  Zhuojun Zhao; Christopher J McKee; Jacques J Kessl; Webster L Santos; Janet E Daigle; Alan Engelman; Gregory Verdine; Mamuka Kvaratskhelia
Journal:  J Biol Chem       Date:  2007-12-19       Impact factor: 5.157

8.  Differential multimerization of Moloney murine leukemia virus integrase purified under nondenaturing conditions.

Authors:  Rodrigo A Villanueva; Colleen B Jonsson; Jennifer Jones; Millie M Georgiadis; Monica J Roth
Journal:  Virology       Date:  2003-11-10       Impact factor: 3.616

9.  Model of full-length HIV-1 integrase complexed with viral DNA as template for anti-HIV drug design.

Authors:  Rajeshri G Karki; Yun Tang; Terrence R Burke; Marc C Nicklaus
Journal:  J Comput Aided Mol Des       Date:  2005-06-27       Impact factor: 3.686

Review 10.  HIV resistance to raltegravir.

Authors:  Francois Clavel
Journal:  Eur J Med Res       Date:  2009-11-24       Impact factor: 2.175

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.